|
US4235871A
(en)
*
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4235877A
(en)
*
|
1979-06-27 |
1980-11-25 |
Merck & Co., Inc. |
Liposome particle containing viral or bacterial antigenic subunit
|
|
US4391904A
(en)
*
|
1979-12-26 |
1983-07-05 |
Syva Company |
Test strip kits in immunoassays and compositions therein
|
|
US4501728A
(en)
*
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US5019369A
(en)
*
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4945050A
(en)
*
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US5036006A
(en)
*
|
1984-11-13 |
1991-07-30 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US4797368A
(en)
*
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
US5139941A
(en)
*
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US4946778A
(en)
*
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US4837028A
(en)
*
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5219740A
(en)
*
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
US5132405A
(en)
*
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US5591624A
(en)
*
|
1988-03-21 |
1997-01-07 |
Chiron Viagene, Inc. |
Retroviral packaging cell lines
|
|
US4923967A
(en)
*
|
1988-09-26 |
1990-05-08 |
Eli Lilly And Company |
Purification and refolding of recombinant proteins
|
|
GB8823869D0
(en)
*
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5703055A
(en)
*
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5221607A
(en)
*
|
1989-09-18 |
1993-06-22 |
Scios Nova Inc. |
Assays and reagents for amyloid deposition
|
|
US5286634A
(en)
*
|
1989-09-28 |
1994-02-15 |
Stadler Joan K |
Synergistic method for host cell transformation
|
|
US5279833A
(en)
*
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5235043A
(en)
*
|
1990-04-06 |
1993-08-10 |
Synergen, Inc. |
Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins
|
|
US5204253A
(en)
*
|
1990-05-29 |
1993-04-20 |
E. I. Du Pont De Nemours And Company |
Method and apparatus for introducing biological substances into living cells
|
|
US5308854A
(en)
*
|
1990-06-18 |
1994-05-03 |
Merck & Co., Inc. |
Inhibitors of HIV reverse transcriptase
|
|
US5252463A
(en)
*
|
1990-06-22 |
1993-10-12 |
The Du Pont Merck Pharmaceutical Company |
Clipsin, a chymotrypsin-like protease and method of using same
|
|
US5200339A
(en)
*
|
1990-08-17 |
1993-04-06 |
Abraham Carmela R |
Proteases causing abnormal degradation of amyloid β-protein precursor
|
|
ATE300615T1
(de)
*
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
US5625126A
(en)
*
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
*
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5545806A
(en)
*
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5633425A
(en)
*
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5187074A
(en)
*
|
1990-10-11 |
1993-02-16 |
Merck & Co., Inc. |
Method of hydroxylation with ATCC 55086
|
|
US5192668A
(en)
*
|
1990-10-11 |
1993-03-09 |
Merck & Co., Inc. |
Synthesis of protease inhibitor
|
|
US5173414A
(en)
*
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
WO1993008184A1
(en)
*
|
1991-10-23 |
1993-04-29 |
Merck & Co., Inc. |
Hiv protease inhibitors
|
|
US5413999A
(en)
*
|
1991-11-08 |
1995-05-09 |
Merck & Co., Inc. |
HIV protease inhibitors useful for the treatment of AIDS
|
|
IL105793A0
(en)
*
|
1992-05-28 |
1993-09-22 |
Lilly Co Eli |
Protease and related dna compounds
|
|
US5665720A
(en)
*
|
1992-08-07 |
1997-09-09 |
Merck & Co., Inc. |
Benzoxazinones as inhibitors of HIV reverse transcriptase
|
|
US5679647A
(en)
*
|
1993-08-26 |
1997-10-21 |
The Regents Of The University Of California |
Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
|
|
US5804566A
(en)
*
|
1993-08-26 |
1998-09-08 |
The Regents Of The University Of California |
Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
|
|
US6015686A
(en)
*
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
AU7973994A
(en)
*
|
1993-10-13 |
1995-05-04 |
Merck & Co., Inc. |
Combination therapy for hiv infection
|
|
US5739118A
(en)
*
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US5476874A
(en)
*
|
1994-06-22 |
1995-12-19 |
Merck & Co., Inc. |
New HIV protease inhibitors
|
|
US5736524A
(en)
*
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
|
US5986054A
(en)
*
|
1995-04-28 |
1999-11-16 |
The Hospital For Sick Children, Hsc Research And Development Limited Partnership |
Genetic sequences and proteins related to alzheimer's disease
|
|
US5922687A
(en)
*
|
1995-05-04 |
1999-07-13 |
Board Of Trustees Of The Leland Stanford Junior University |
Intracellular delivery of nucleic acids using pressure
|
|
US5744346A
(en)
*
|
1995-06-07 |
1998-04-28 |
Athena Neurosciences, Inc. |
β-secretase
|
|
US6221645B1
(en)
*
|
1995-06-07 |
2001-04-24 |
Elan Pharmaceuticals, Inc. |
β-secretase antibody
|
|
US6329163B1
(en)
*
|
1995-06-07 |
2001-12-11 |
Elan Pharmaceuticals, Inc. |
Assays for detecting β-secretase inhibition
|
|
US5942400A
(en)
*
|
1995-06-07 |
1999-08-24 |
Elan Pharmaceuticals, Inc. |
Assays for detecting β-secretase
|
|
US5978740A
(en)
*
|
1995-08-09 |
1999-11-02 |
Vertex Pharmaceuticals Incorporated |
Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them
|
|
US5846978A
(en)
*
|
1996-05-02 |
1998-12-08 |
Merck & Co., Inc. |
HIV protease inhibitors useful for the treatment of AIDS
|
|
US6207710B1
(en)
*
|
1996-11-22 |
2001-03-27 |
Elan Pharmaceuticals, Inc. |
Compounds for inhibiting β-amyloid peptide release and/or its synthesis
|
|
GB9701684D0
(en)
*
|
1997-01-28 |
1997-03-19 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6077682A
(en)
*
|
1998-03-19 |
2000-06-20 |
University Of Medicine And Dentistry Of New Jersey |
Methods of identifying inhibitors of sensor histidine kinases through rational drug design
|
|
US6844148B1
(en)
*
|
1998-09-24 |
2005-01-18 |
Pharmacia & Upjohn Company |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
|
US6699671B1
(en)
*
|
1998-09-24 |
2004-03-02 |
Pharmacia & Upjohn Company |
Alzheimer's disease secretase, APP substrates therefor, and uses therefor
|
|
US20040234976A1
(en)
*
|
1998-09-24 |
2004-11-25 |
Gurney Mark E. |
Alzheimer's disease secretase, app substrates therefor, and uses therefor
|
|
US6245884B1
(en)
*
|
1998-10-16 |
2001-06-12 |
Vivian Y. H. Hook |
Secretases related to alzheimer's dementia
|
|
US6313268B1
(en)
*
|
1998-10-16 |
2001-11-06 |
Vivian Y. H. Hook |
Secretases related to Alzheimer's dementia
|
|
US7115410B1
(en)
*
|
1999-02-10 |
2006-10-03 |
Elan Pharmaceuticals, Inc. |
β-secretase enzyme compositions and methods
|
|
CN1390232A
(zh)
*
|
1999-02-10 |
2003-01-08 |
艾兰制药公司 |
人β分泌酶、抑制剂、其组合物和用途
|
|
WO2000058479A1
(en)
*
|
1999-03-26 |
2000-10-05 |
Amgen Inc. |
Beta secretase genes and polypeptides
|
|
EP1496124A1
(en)
*
|
1999-06-28 |
2005-01-12 |
Oklahoma Medical Research Foundation |
Catalytically active recombinant memapsin and methods of use thereof
|
|
EP1196609A2
(en)
*
|
1999-06-28 |
2002-04-17 |
Oklahoma Medical Research Foundation |
Catalytically active recombinant memapsin and methods of use thereof
|
|
US6361975B1
(en)
*
|
1999-11-16 |
2002-03-26 |
Smithkline Beecham Corporation |
Mouse aspartic secretase-2(mASP-2)
|
|
US6291223B1
(en)
*
|
1999-11-23 |
2001-09-18 |
Smithkline Beecham Corporation |
Mouse aspartic secretase-1 (mASP1)
|
|
US6713276B2
(en)
*
|
2000-06-28 |
2004-03-30 |
Scios, Inc. |
Modulation of Aβ levels by β-secretase BACE2
|
|
AU2001281250A1
(en)
*
|
2000-08-11 |
2002-02-25 |
The Brigham And Women's Hospital, Inc. |
(hydroxyethyl)ureas as inhibitors of alzheimer's beta-amyloid production
|
|
US7630838B2
(en)
*
|
2000-09-22 |
2009-12-08 |
American Home Products Corporation |
Method for identifying agents that interact with beta-site APP cleaving enzyme (BACE)
|
|
AU2002243391A1
(en)
*
|
2000-10-27 |
2002-06-24 |
The Johns Hopkins University School Of Medicine |
Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof
|
|
US20040121947A1
(en)
*
|
2000-12-28 |
2004-06-24 |
Oklahoma Medical Research Foundation |
Compounds which inhibit beta-secretase activity and methods of use thereof
|
|
AU2002239727C1
(en)
*
|
2000-12-28 |
2005-12-22 |
Oklahoma Medical Research Foundation |
Inhibitors of memapsin 2 and use thereof
|
|
AU2006279896A1
(en)
*
|
2005-08-10 |
2007-02-22 |
Oklahoma Medical Research Foundation |
Truncated memapsin 2 for use for treating Alzheimer's disease
|